135 related articles for article (PubMed ID: 12148543)
1. Antiphospholipid antibodies and kininogens in pathologic pregnancies: a review.
Sugi T; Makino T
Am J Reprod Immunol; 2002 May; 47(5):283-8. PubMed ID: 12148543
[TBL] [Abstract][Full Text] [Related]
2. Kininogen-dependent antiphosphatidylethanolamine antibodies and autoantibodies to factor XII in patients with recurrent pregnancy losses.
Sugi T
J Obstet Gynaecol Res; 2013 Jul; 39(7):1223-9. PubMed ID: 23803004
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies to contact proteins in patients with recurrent pregnancy losses.
Sugi T; Makino T
J Reprod Immunol; 2002 Jan; 53(1-2):269-77. PubMed ID: 11730922
[TBL] [Abstract][Full Text] [Related]
4. Factor XII, kininogen and plasma prekallikrein in abnormal pregnancies.
Sugi T; Makino T
Curr Drug Targets; 2005 Aug; 6(5):551-7. PubMed ID: 16026275
[TBL] [Abstract][Full Text] [Related]
5. Plasma contact system, kallikrein-kinin system and antiphospholipid-protein antibodies in thrombosis and pregnancy.
Sugi T; Makino T
J Reprod Immunol; 2000 Jul; 47(2):169-84. PubMed ID: 10924749
[TBL] [Abstract][Full Text] [Related]
6. Certain autoantibodies to phosphatidylethanolamine (aPE) recognize factor XI and prekallikrein independently or in addition to the kininogens.
Sugi T; McIntyre JA
J Autoimmun; 2001 Nov; 17(3):207-14. PubMed ID: 11712858
[TBL] [Abstract][Full Text] [Related]
7. Autoantibodies to phosphatidylethanolamine (PE) recognize a kininogen-PE complex.
Sugi T; McIntyre JA
Blood; 1995 Oct; 86(8):3083-9. PubMed ID: 7579402
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies to Factor XII and Kininogen-Dependent Antiphosphatidylethanolamine Antibodies in Patients with Recurrent Pregnancy Loss Augment Platelet Aggregation.
Sato Y; Sugi T; Sakai R
Am J Reprod Immunol; 2015 Sep; 74(3):279-89. PubMed ID: 26011374
[TBL] [Abstract][Full Text] [Related]
9. Kininogen domain 3 contains regions recognized by antiphosphatidylethanolamine antibodies.
Katsunuma J; Sugi T; Inomo A; Matsubayashi H; Izumi SI; Makino T
J Thromb Haemost; 2003 Jan; 1(1):132-8. PubMed ID: 12871550
[TBL] [Abstract][Full Text] [Related]
10. Antiphosphatidylethanolamine antibodies in recurrent early pregnancy loss and mid-to-late pregnancy loss.
Sugi T; Matsubayashi H; Inomo A; Dan L; Makino T
J Obstet Gynaecol Res; 2004 Aug; 30(4):326-32. PubMed ID: 15238112
[TBL] [Abstract][Full Text] [Related]
11. Prevalence and heterogeneity of antiphosphatidylethanolamine antibodies in patients with recurrent early pregnancy losses.
Sugi T; Katsunuma J; Izumi S; McIntyre JA; Makino T
Fertil Steril; 1999 Jun; 71(6):1060-5. PubMed ID: 10360910
[TBL] [Abstract][Full Text] [Related]
12. Antiphosphatidylethanolamine antibodies might not be an independent risk factor for further miscarriage in patients suffering recurrent pregnancy loss.
Obayashi S; Ozaki Y; Sugi T; Kitaori T; Katano K; Suzuki S; Sugiura-Ogasawara M
J Reprod Immunol; 2010 Jun; 85(2):186-92. PubMed ID: 20462639
[TBL] [Abstract][Full Text] [Related]
13. Plasma contact activation: a revised hypothesis.
Schmaier AH
Biol Res; 1998; 31(3):251-62. PubMed ID: 9830513
[TBL] [Abstract][Full Text] [Related]
14. Anti-phosphatidylethanolamine (aPE) antibodies: a survey.
Mcintyre JA; Wagenknecht DR
J Autoimmun; 2000 Sep; 15(2):185-93. PubMed ID: 10968907
[TBL] [Abstract][Full Text] [Related]
15. Different antiphospholipid antibody specificities are found in association with early repeated pregnancy loss versus recurrent IVF-failure patients.
Matsubayashi H; Sugi T; Arai T; Kondo A; Suzuki T; Izumi S; McIntyre JA; Makino T
Am J Reprod Immunol; 2001 Nov; 46(5):323-9. PubMed ID: 11712760
[TBL] [Abstract][Full Text] [Related]
16. Antiphosphatidylethanolamine antibodies as the only antiphospholipid antibodies detected by ELISA. II. Kininogen reactivity.
Boffa MC; Berard M; Sugi T; McIntyre JA
J Rheumatol; 1996 Aug; 23(8):1375-9. PubMed ID: 8856616
[TBL] [Abstract][Full Text] [Related]
17. Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.
Scott CF; Silver LD; Schapira M; Colman RW
J Clin Invest; 1984 Apr; 73(4):954-62. PubMed ID: 6561202
[TBL] [Abstract][Full Text] [Related]
18. High and low molecular weight kininogen and plasma prekallikrein/plasma kallikrein in villous capillaries of human term placenta.
Hermann A; Buchinger P; Somlev B; Rehbock J
Placenta; 1996 May; 17(4):223-30. PubMed ID: 8761966
[TBL] [Abstract][Full Text] [Related]
19. Phosphatidylethanolamine induces specific conformational changes in the kininogens recognizable by antiphosphatidylethanolamine antibodies.
Sugi T; Mclntyre JA
Thromb Haemost; 1996 Sep; 76(3):354-60. PubMed ID: 8883270
[TBL] [Abstract][Full Text] [Related]
20. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.
Wiggins RC; Bouma BN; Cochrane CG; Griffin JH
Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4636-40. PubMed ID: 270705
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
